Management of Cough in Patients with Chronic Obstructive Pulmonary Disease: Results of the Multicenter Randomized Placebo-Controlled Clinical Trial

BACKGROUND: Chronic cough declines quality of life and increases risk of complications in patients with chronic obstructive pulmonary disease (COPD). Reducing cough severity and associated negative effects is important therapeutic goal in COPD. Rengalin with anti- and protussive activity is based on...

Descripción completa

Detalles Bibliográficos
Autores principales: Avdeev, Sergey N, Vizel, Alexander A, Abrosimov, Vladimir N, Zaicev, Andrey A, Ignatova, Galina L, Khamitov, Rustem F, Mikhaylusova, Marina P, Shapovalova, Julia S, Pavlysh, Elena F, Trofimov, Basil I, Emelyanov, Alexander V, Martynenko, Tatiana I, Martynenko, Vladimir A, Kostina, Natalia E, Chizhov, Danila A, Chizhova, Olga Yu, Kuzubova, Natalia A, Makova, Elena V, Makarova, Ekaterina V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Clinical Trial Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107011/
https://www.ncbi.nlm.nih.gov/pubmed/33981141
http://dx.doi.org/10.2147/COPD.S292109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107011/
https://www.ncbi.nlm.nih.gov/pubmed/33981141
http://dx.doi.org/10.2147/COPD.S292109

Ejemplares similares